Phase I and pharmacokinetic study of the novel MDR1 and MRP1 inhibitor biricodar administered alone and in combination with doxorubicin

R. A. Peck, J. Hewett, M. W. Harding, Y. M. Wang, P. R. Chaturvedi, A. Bhatnagar, H. Ziessman, F. Atkins, M. J. Hawkins

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase I and pharmacokinetic study of the novel MDR1 and MRP1 inhibitor biricodar administered alone and in combination with doxorubicin'. Together they form a unique fingerprint.

Medicine & Life Sciences